
EKSO BIONICS HOLDINGS, INC.
100
Recent developments include the completion of a business combination and holding company restructuring in 2026, a strategic partnership with Microsoft to deploy AI compute capacity, and a partnership with Nutanix to deliver enterprise AI infrastructure.
- On May 5, 2026, Ekso consummated a business combination transaction, restructuring its operations to include the Cloud Business and Legacy Ekso Business, with the latter designated held for sale [S1].
- On July 1, 2026, the company completed a holding company formation transaction, creating ChronoScale Holdings as the public parent company [S1].
- On August 6, 2026, the company changed its principal place of business to Menlo Park, California [S1].
- On August 6, 2026, Ekso entered a two-year strategic partnership with Microsoft to deploy approximately 50 megawatts of AI compute capacity using NVIDIA GB300 systems and advanced liquid cooling, subject to financing and operational conditions [S1].
- The company announced a strategic partnership with Nutanix to jointly deliver enterprise-ready AI infrastructure, enabling integration of Nutanix on-premises environments with Ekso's GPU-as-a-Service and AI platforms [S1].
Ekso Bionics Holdings, Inc. transitioned in 2026 from a dual-segment company to focusing solely on its Cloud Business, which provides GPU computing infrastructure for AI, machine learning, and high-performance computing workloads. The Cloud Business operates through ChronoScale Corporation, managing GPU capacity deployed in third-party colocation centers in Colorado, Minnesota, and Utah. The company’s primary customer is Together AI, which utilizes approximately 6,144 NVIDIA H100 GPUs under a fixed-rate contract. The Legacy Ekso Business, focused on exoskeleton products for healthcare and rehabilitation, has been designated held for sale with divestiture planned in fiscal 2027. The company’s growth strategy centers on a four-layer platform integrating infrastructure (NeoCloud Platform), compute (GPU-as-a-Service), AI platform capabilities (Token Factory and ChronoScale Foundry), and implementation services (Outcome Engineers). Strategic partnerships with Microsoft and Nutanix aim to expand AI compute capacity and enterprise AI adoption. The company faces a highly competitive AI cloud market with significant customer concentration and liquidity constraints.
Financial figures (if any) are summarized from the latest available SEC filings and are provided for informational purposes only — not financial advice. Ekso Bionics Holdings, Inc. operates primarily through its Cloud Business, providing GPU-based AI and high-performance computing services via colocation centers in three U.S. states. The company has divested its Legacy Ekso exoskeleton business, which is classified as held for sale. The Cloud Business is highly concentrated with one customer accounting for nearly all revenue. The company reported a net loss of $50.3 million for fiscal year 2026, with limited liquidity and a working capital deficit. Strategic partnerships with Microsoft and Nutanix support expansion of AI compute capacity and enterprise AI infrastructure. The company faces competitive pressures and execution risks related to customer concentration, capital requirements, and market dynamics [S1][S2].
The company’s early adoption and deployment of advanced GPU technology, including NVIDIA H100 GPUs, position it to serve growing demand for AI and high-performance computing infrastructure. Its integrated platform approach, combining infrastructure, compute services, AI workload management, and enterprise AI workflow governance, addresses diverse customer needs. Strategic partnerships with Microsoft and Nutanix provide access to expanded AI compute capacity and enterprise markets. The company’s operational experience managing large-scale AI infrastructure supports potential for efficient scaling and customer service.
The company faces significant risks from high customer concentration, with one customer accounting for nearly all Cloud Business revenue, which could materially impact results if lost. Liquidity constraints and ongoing net losses raise concerns about the ability to sustain operations without additional capital. The divestiture of the Legacy Ekso Business represents a major strategic shift with execution risks. The AI cloud market is highly competitive, with larger, better-resourced competitors potentially limiting market share growth. Dependence on key suppliers like Nvidia and the need to secure financing for expansion projects add to operational risks.
Ekso Bionics Holdings, Inc.'s moat is primarily based on its early deployment of next-generation GPU infrastructure, including NVIDIA H100 GPUs, and its integrated platform approach combining infrastructure, compute services, AI platform capabilities, and implementation support. Strategic partnerships with major technology companies like Microsoft and Nutanix enhance its market positioning. However, the company faces significant competition from larger cloud service providers with broader geographic reach, greater resources, and established customer relationships. Customer concentration and reliance on key suppliers such as Nvidia also present challenges to sustaining competitive advantages.
• Customer Concentration Risk: One customer accounted for approximately 99.5% of total revenue in fiscal 2026, creating significant dependency and risk if the customer terminates or reduces usage.
• Liquidity and Capital Requirements: The company had a working capital deficit and limited cash as of May 31, 2026, and its ability to continue operations depends on raising additional capital and managing cash flow.
• Competitive Market: The AI cloud infrastructure market is highly competitive with larger providers having advantages in scale, resources, and geographic reach.
• Execution Risk in Strategic Shift: The divestiture of the Legacy Ekso Business and focus on the Cloud Business represent a major operational change with associated risks in execution and financial impact.
• Supplier Dependence: The company relies primarily on Nvidia for GPU chips and plans to rely on AMD, exposing it to supply chain risks and pricing pressures.
Business trends: The company is shifting focus to AI cloud infrastructure, expanding GPU capacity and platform services, and forming strategic partnerships to broaden enterprise AI adoption.
Execution milestones: Completion of Legacy Ekso divestiture, deployment of Microsoft AI compute capacity, and expansion of customer base beyond current concentration.
Key risks: High customer concentration, liquidity and capital needs, competitive pressures, execution risks in strategic shift, and supplier dependence.
Very high visibility
Visibility score reflects the breadth and consistency of available disclosure across SEC filings, recent public reporting, and baseline business context (research-only; not investment advice).
- Ekso Bionics Holdings, Inc. operates through two wholly-owned subsidiaries: ChronoScale Corporation (formerly Applied Digital Cloud Corporation) and Ekso Bionics, Inc. (Legacy Ekso).
- Following a business combination and holding company transaction in 2026, the company restructured to focus on cloud services through ChronoScale Corporation and designated the Legacy Ekso business as held for sale.
- The Cloud Business provides GPU computing solutions for AI, machine learning, rendering, and high-performance computing workloads, operating in colocation centers in Colorado, Minnesota, and Utah.
- As of May 31, 2026, the Cloud Business had one customer, Together AI, which uses approximately 6,144 NVIDIA H100 GPUs under a master terms of service agreement renewed in March 2026.
- Cloud Business revenue accounted for approximately 99.5% of total revenue for the fiscal year ended May 31, 2026.
- The company plans to divest the Legacy Ekso Business, which designs and markets exoskeleton products primarily for healthcare and rehabilitation, with divestiture expected during fiscal year 2027.
- The company’s growth strategy for the Cloud Business is based on a four-layer platform integrating infrastructure (NeoCloud Platform), compute (GPU-as-a-Service), AI platform capabilities (Token Factory and ChronoScale Foundry), and implementation services (Outcome Engineers).
- The NeoCloud Platform consists of leased data centers, secured power capacity, and network connectivity designed to support AI workloads with redundancy and reliability.
- GPU-as-a-Service offers dedicated GPU infrastructure on a contracted basis, managed via a unified orchestration platform across cloud and on-premises environments.
- The Token Factory is a managed inference platform allowing usage-based AI compute consumption with governance and performance monitoring.
- ChronoScale Foundry is an enterprise AI platform for building and governing agentic AI workflows on-premises, supporting security and compliance.
- Outcome Engineers provide technical and domain-specific support to customers for platform integration and optimization.
- The company has strategic partnerships, including a two-year agreement with Microsoft to deploy approximately 50 megawatts of AI compute capacity using NVIDIA GB300 systems and advanced liquid cooling, and a partnership with Nutanix to deliver enterprise AI infrastructure.
- The AI cloud market is highly competitive with competitors such as CoreWeave, Crusoe Energy, Lambda Labs, and Nebius Group, many of which have broader geographic presence and more resources.
- Industry trends include rapid growth in AI infrastructure spending driven by AI training and inference workloads, with increasing importance of energy availability, cost, and sustainability in data center operations.
- As of May 31, 2026, the company had cash and cash equivalents of approximately $9.7 million and a working capital deficit of $42.6 million.
- Liquidity ratios as of May 31, 2026, include a current ratio of 0.51 and a cash ratio of 0.11, indicating limited short-term liquidity.
- For the fiscal year ended May 31, 2026, the company reported a net loss of $50.3 million and basic and diluted EPS of -$0.36 per share.
- Revenue decreased 15% from the prior year, primarily due to loss of a customer in December 2024.
- Cost of revenues decreased 23% due to lower depreciation, amortization, lease expenses, and personnel costs, partially offset by increased energy costs.
- Selling, general and administrative expenses decreased 20% year-over-year.
- The company completed a business combination transaction on May 5, 2026, and a holding company formation transaction on July 1, 2026, restructuring its corporate structure.
- The Legacy Ekso Business results are presented as discontinued operations from May 5, 2026, onward.
- The company has material customer concentration risk, with one customer accounting for nearly all Cloud Business revenue.
- The company has financing arrangements including a Grid Note with Applied Parent with $7 million drawn and $93 million undrawn as of July 1, 2026.
- The company’s ability to continue as a going concern depends on raising additional capital and successfully operating its Cloud Business.
- The company’s strategic shift to focus solely on the Cloud Business represents a major change in operations and financial results.
- The company’s cloud services are priced at a fixed, per-GPU per-hour rate billed monthly, subject to change.
- The company maintains additional deployable GPU capacity beyond contracted amounts at its colocation centers.
- The company relies primarily on Nvidia for GPU chips and plans to rely on AMD as a secondary supplier.
- The company’s platform layers and strategic partnerships aim to broaden the customer base and accelerate enterprise AI adoption globally.
Generated 2026-08-19
- S1 | 2026-08-19 | 10-K
- S2 | 2026-04-28 | 10-Q
- N1 | 2026-08-19 | www.nasdaq.com | Dollar Tumbles and Gold Prices Jump as US Treasury Boosts Liquidity | https://www.nasdaq.com/articles/dollar-tumbles-and-gold-prices-jump-us-treasury-boosts-liquidity
- N2 | 2026-08-19 | www.nasdaq.com | Red Robin (RRGB) Q2 2026 Earnings Call Transcript | https://www.nasdaq.com/articles/red-robin-rrgb-q2-2026-earnings-call-transcript
- N3 | 2026-08-19 | www.nasdaq.com | Atea (AVIR) Q2 2026 Earnings Call Transcript | https://www.nasdaq.com/articles/atea-avir-q2-2026-earnings-call-transcript
- N4 | 2026-08-19 | www.nasdaq.com | Spire Global (SPIR) Q2 2026 Earnings Call Transcript | https://www.nasdaq.com/articles/spire-global-spir-q2-2026-earnings-call-transcript
- N5 | 2026-08-19 | www.nasdaq.com | LPA (LPA) Q2 2026 Earnings Call Transcript | https://www.nasdaq.com/articles/lpa-lpa-q2-2026-earnings-call-transcript
- N6 | 2026-08-19 | www.nasdaq.com | Kura Oncology (KURA) Q2 2026 Earnings Call Transcript | https://www.nasdaq.com/articles/kura-oncology-kura-q2-2026-earnings-call-transcript
- N7 | 2026-08-19 | www.nasdaq.com | Dollar Slumps and Gold Rallies as US Treasury Ramps Up Buybacks | https://www.nasdaq.com/articles/dollar-slumps-and-gold-rallies-us-treasury-ramps-buybacks
- N8 | 2026-08-19 | www.nasdaq.com | Corn Holding onto Wednesday Gains | https://www.nasdaq.com/articles/corn-holding-wednesday-gains
This material is for informational purposes only and does not constitute investment, financial, legal or tax advice, or an offer or solicitation to buy or sell any security. The Valye AI Score is a model-based estimate derived from public information and is subject to change without notice. No representation or warranty, express or implied, is made as to the accuracy, completeness or fairness of the information herein. Past performance is not indicative of future results. Investors should conduct their own research and consult a qualified financial adviser before making any investment decisions.

Generated by Valye SEC Pipeline Engine
.gif)


